EIR Ventures

EIR Ventures is a life science venture capital firm supported by InnovFin Equity and Saminvest AB. They focus on financing the development of innovative medicine and have a portfolio of companies across various therapeutic areas.


📥 Buy Full VC Dataset

Offices: Stockholm (Sweden), Copenhagen (Denmark)

Investment Stages: Series A, Series B

Markets: Life Science

Founded Year:

Investor Type: Venture Capital

Portfolio Companies: Moleculent, RAPP, GutCRINE, Hoba Therapeutics, Scenic Biotech, SACRA Therapeutics, ArgusEye, Pretzel, IO Biotech, Galecto Biotech, Purpose Pharma, Henlez, Attgeno, Cinclus Pharma, Strike Pharma, Dania Tx, ISD-Immunotech, one-carbon Therapeutics, Synklino, Sortina Pharma

Website: https://eirventures.eu

Team Page: https://eirventures.eu/team/

Portfolio Link: https://eirventures.eu/investments/

LinkedIn:

Twitter:

Instagram:

Crunchbase:

Pitchbook:


Leave a Comment